Figure 2.

Association of receipt of “Best Care” with secondary cancer therapy at 5 years among prostate cancer patients with low-risk (panel A) and high-risk (panel B) disease. All values are back transformed from Cox regression models and adjusted for the covariates shown in Table 1. * Receipt of radiotherapy without concurrent androgen-deprivation therapy (ADT) for high-risk disease is not adherent to quality measures and therefore no patients in this group received “Best Care”.